Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Genzyme Transgenics receives further funding for development of transgenic ATIII

April 1, 1997

Terumo claims platelet aggregation/thromboxane synthase inhibitors

April 1, 1997

Antiplatelet 5-HT2A receptor antagonist characterized by Toa Eiyo

March 27, 1997

Novel orally active antithrombotic agent from Fuji Yakuhin

March 27, 1997

Biological role of CD39 uncovered by Immunex and collaborators

March 26, 1997

Biogen licenses Hirulog

March 26, 1997

Cor Therapeutics receives nonapprovable letter for Integrilin NDA

March 26, 1997

CPMP approves lepirudin

March 24, 1997

RPR seeks FDA approval for new indications for Lovenox

March 24, 1997

Promising phase II data presented for Novastan in acute MI

March 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...